8 completed, 1 recruiting. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 8, Recruiting 1 |
Follow Meningococcal Infection: new trials by email Literature Review of Meningococcal Infection trials Research Report on Meningococcal Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China MenQuadfi® (Meningococcal Polysaccharide [Serogroups A, C, W, and Y] Tetanus Toxoid Conjugate Vaccine) (Sanofi Pasteur Inc., Swiftwater, PA, USA), Menhycia® (ACYW135 Meningococcal Conjugate Vaccine [CRM197]) (CanSino Biologics Inc., China) - Meningococcal Infection, Healthy Volunteers | Phase 3 | Recruiting | Sanofi | 4568 | 2026-08-22 | 2026-10-19 |
| Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China MenACYW conjugate vaccine, MenACYW135 polysaccharide vaccine, MenAC conjugate vaccine - Meningococcal Infection, Healthy Volunteers | Phase 3 | Completed | Sanofi | 1602 | 2025-09-26 | 2026-10-19 |
| Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine - Meningococcal Infection, Healthy Volunteers | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 447 | 2024-01-18 | 2025-09-17 |
| Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation Meningococcal Diphtheria Toxoid Vaccine - Meningitis, Meningococcal Infection | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 300 | 2013-06-25 | 2022-04-19 |
| Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose blood sampling, bivalent rLP2086 - Meningococcal Infection | Phase 3 | Completed | Pfizer | 698 | 2012-09-07 | 2020-03-27 |
| Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers Meningococcal vaccine GSK 134612, SynflorixTM, Infanrix-IPV/HiberixTM - Meningococcal Infection | Phase 3 | Completed | GlaxoSmithKline | 753 | 2012-01-27 | 2019-08-06 |
| Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®, Meningococcal Group C Conjugate vaccine: MenC - Meningitis, Meningococcal Infection | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 123 | 2011-05-01 | 2016-08-19 |
| A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India Meningococcal Polysaccharide Diphtheria Toxoid Conjugate (Menactra®) - Meningococcal Infection, Meningitis | Phase 3 | Completed | Sanofi | 300 | 2010-06-01 | 2012-02-06 |
| Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants MenACWY-CRM197, DTaP (Diptheria, Tetanus, Pertussis) Vaccine, Hib (Haemophilus influenza b) Vaccine - Meningitis, Meningococcal Infection | Phase 3 | Completed | Novartis | 7744 | 2008-12-01 | 2013-07-09 |
Meningococcal Infections (9) · Meningitis (4) · Meningitis, Bacterial (1)
Bacterial Infections (9) · Bacterial Infections and Mycoses (9) · Gram-Negative Bacterial Infections (9) · Infections (9) · Neisseriaceae Infections (9) · Nervous System Diseases (4) · Neuroinflammatory Diseases (4) · Central Nervous System Bacterial Infections (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1)
Meningococcal Vaccines (3) · Blood Specimen Collection (1) · CRM197 (non-toxic variant of diphtheria toxin) (1) · Chickenpox Vaccine (1) · Hepatitis A Vaccines (1) · Pneumococcal Vaccines (1) · Poliovirus Vaccine, Inactivated (1) · Tetanus Toxoid (1) · Vaccines (1)
Sanofi (3) · Sanofi Pasteur, a Sanofi Company (3) · GlaxoSmithKline (1) · Novartis (1) · Pfizer (1)
China (3) · India (2) · United States (2) · Canada (1) · Costa Rica (1) · Czechia (1) · Denmark (1) · Finland (1) · Germany (1) · Guatemala (1) · Lebanon (1) · Mexico (1) · Panama (1) · Peru (1) · Russia (1)